Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
BE PART OF RESEARCH logo

On International Clinical Trials Day this year, NIHR launched its ‘Be Part of Research’ campaign – aiming to provide a source of information for people to find out what research is currently taking place across the UK. The campaign raised awareness by featuring real life stories of patients who have been successfully involved in clinical research.

As part of the campaign, the Be Part of Research (formerly UKCTG) website was launched, and this continues to run as an excellent resource for anyone working or interested in clinical trials, providing details on what research is about and the many ways to get involved, as well as a listing of all studies currently taking place across the UK. The website has a search function to allow you to look through this listing for research on particular conditions or drugs, or find out where there may be studies running near you.

Again, this is a wonderful resource and OCTRU wholeheartedly recommend that you visit the website at https://bepartofresearch.nihr.ac.uk/ and take a look around!

 

 

Similar stories

WHiTE Four trial results!

OCTRU

The WHiTE Four trial has now published its results in The Bone & Joint journal.

FUTURE GB Trial opens to recruitment!

OCTRU

The FUTURE GB Trial has received OCTRU Green Light approval and is now open to recruitment!

ARCADIAN trial opens to recruitment!

OCTRU

The ARCADIAN trial has received OCTRU Green Light approval and has now begun to open sites to recruitment!

HOPE-e study resumes recruitment of women with painful osteoarthritis in the hand

Main OCTRU

Researchers in Oxford are looking to recruit women who have painful osteoarthritis in joints of their hands, after resuming a study that was paused due to the COVID crisis.

HUSH trial opens to recruitment!

OCTRU

The HUSH trial has received OCTRU Green Light approval and is now open to recruitment!

Oxford researchers start new trial on the use of anti-TNF to treat Covid-19 in care homes

Main OCTRU Trials

Researchers at the University of Oxford are starting a new study to explore the effectiveness of the anti-tumour necrosis factor (anti-TNF) drug adalimumab as a treatment for patients with COVID-19 in the community, especially care homes. The AVID-CC trial, which will be conducted by Oxford Clinical Trials Research Unit (OCTRU), will enrol up to 750 patients from community care settings throughout the UK.